TBPH
$25.84
Theravance Bio Ord
($.46)
(1.75%)
TBPH
Earnings Whisper ®
N/A
2nd Quarter June 2020
Consensus:  ($1.02)
Revenue:  $23.04 Mil
Wednesday
Aug 5
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TBPH reports earnings?
Beat
Meet
Miss

Where is TBPH's stock price going from here?
Up
Flat
Down
Stock chart of TBPH
Analysts
Summary of analysts' recommendations for TBPH
Score
Grade
Pivots
Resistance
$27.89
$27.43
$26.87

$26.41

Support
$25.85
$25.39
$24.83
Tweet
Growth
Peers
Regeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalJohnson & JohnsonInterCeptZoetisMylanBristol-Myers SquibbUltragenyx PharmaceuticalEndo International plc